Oaktree Acquisition Corp. Iii Life Sciences · NASDAQ:OACC
Barclays PLC reported a 7.19% stake in Oaktree Acquisition Corp. Iii Life Sciences (Schedule 13G)
Event Mar 31, 2025 · Filed May 13, 2025
Barclays PLC reported a 7.19% stake in Oaktree Acquisition Corp. Iii Life Sciences, 1,299,125 shares, as a passive investor on Mar 31, 2025. Filed May 13, 2025 (Schedule 13G).
- Stake
- 7.19%
- Shares
- 1,299,125
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Barclays PLC | 7.19% | 1,299,125 |
Source
Related
- Oaktree Acquisition Corp. Iii Life Sciences
- Barclays PLC
- Oaktree Acquisition Corp. Iii Life Sciences shareholders
- Schedule 13G · Barclays PLC · Aug 13, 2026
- Schedule 13G/A · Barclays PLC · Feb 11, 2026
- Schedule 13G · Decagon Asset Management LLP · Aug 14, 2026
- Schedule 13G · Fort Baker Capital Management LP · May 15, 2026
- Schedule 13G · Goldman Sachs Group Inc · May 11, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · Aug 12, 2025
- Schedule 13G/A · Millennium Management LLC · Jul 15, 2025